Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-12-03Clinical Trial Update: The Effect of Duloxetine on Mood, Quality of Life and Cognitive Functioning in Glioblastoma Patients [Phase 3]
A Phase 3 trial assessed duloxetine for mood, quality of life, and cognitive functioning in glioblastoma patients; the study has been termin…
-
CLINICAL_TRIALS trial_result · 2015-12-02Clinical Trial Update: Open Pilot Trial of TES for Depression [Phase 2]
An open pilot Phase 2 trial evaluating transcranial electrical stimulation (TES) for major depressive disorder has completed.
-
CLINICAL_TRIALS trial_result · 2015-12-02Clinical Trial Update: Investigating tDCS as a Treatment for Unipolar and Bipolar Depression [Phase 2, Phase 3]
This clinical trial update covers phase 2 and phase 3 studies evaluating transcranial direct current stimulation (tDCS) as a treatment for u…
-
CLINICAL_TRIALS trial_result · 2015-12-02Clinical Trial Update: Enhancing Recovery After Cardiac Surgery [NA]
A completed clinical trial from UCLA focusing on enhancing recovery after cardiac surgery, involving participants with coronary artery disea…
-
CLINICAL_TRIALS trial_result · 2015-12-02Clinical Trial Update: Training Doctors to Support Patient Self-Care of Depression [NA]
A completed clinical trial evaluating a program to train doctors to support patient self-care among individuals with depression (including p…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2015-12-02Clinical Trial Update: Treatment of Insomnia and Depression in Elders (TIDE) [NA]
This clinical trial update concerns the Treatment of Insomnia and Depression in Elders (TIDE) study; it lists depression and insomnia as con…
-
FDA approval · 2015-12-01FDA Approved: CITALOPRAM — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for Citalopram by Mylan Pharmaceuticals Inc., signaling an approved update to the existing generic p…
-
CLINICAL_TRIALS trial_result · 2015-11-30Clinical Trial Update: Pharmacogenomics for Antidepressant Guidance and Education 1 (PAGE-1_AG1) [NA]
Clinical trial update on pharmacogenomics for antidepressant guidance; study terminated with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-11-26Clinical Trial Update: A Study of Fluoxetine in Major Depressive Disorder (MDD) Long-Term Dosing [Phase 3]
Phase 3 long-term dosing study of fluoxetine in adults with Major Depressive Disorder completed, with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-11-26Clinical Trial Update: Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial) [Phase 3]
OPC-34712 was studied as adjunctive therapy in adults with major depressive disorder in a Phase 3 trial. The study is completed and results …
-
CLINICAL_TRIALS research · 2015-11-26Clinical Trial Update: Phospholipid Hypothesis of Depression: From Molecular Biology, Neuroimaging to Behaviour [NA]
A completed Taiwan-based clinical trial investigating the phospholipid hypothesis of depression, integrating molecular biology, neuroimaging…
-
CLINICAL_TRIALS trial_result · 2015-11-25Clinical Trial Update: Post-stroke Triage "DOC": Simple Screening for Depression, Obstructive Sleep Apnea and Cognitive Impairment
Completed clinical trial evaluating a simple screening tool (DOC) for depression, obstructive sleep apnea, and cognitive impairment in post-…
-
FDA approval · 2015-11-24FDA Approved: PROZAC — Supplemental Application (Dista Products Company)
FDA approved a supplemental application for Prozac (fluoxetine hydrochloride) submitted by Dista Products Company.
-
CLINICAL_TRIALS trial_result · 2015-11-24Clinical Trial Update: Physical EXercise as an Adjunct Treatment for Depression [NA]
The clinical trial examining physical exercise as an adjunct treatment for major depressive disorder has completed.
-
CLINICAL_TRIALS trial_result · 2015-11-20Clinical Trial Update: A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD [Phase 3]
Phase 3 trial update for DVS SR in children and adolescents with major depressive disorder; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2015-11-20Clinical Trial Update: Cognitive-behavioral (CBT) in ESRD Patients With Depression [NA]
This completed clinical trial evaluated cognitive-behavioral therapy for depression in patients with chronic kidney disease, including those…
-
CLINICAL_TRIALS research · 2015-11-20Clinical Trial Update: A Trial of a Preventive Intervention Program for Chilean Families With Depressed Parents [NA]
Clinical trial update for a preventive intervention program targeting Chilean families with depressed parents, focusing on depression; the c…
-
CLINICAL_TRIALS trial_result · 2015-11-20Clinical Trial Update: Bupropion Hydrochloride 300 mg Extended Release Tablets Under Fasting Conditions [Phase 1]
A Phase 1 clinical trial of Bupropion hydrochloride extended-release 300 mg under fasting conditions sponsored by Teva has been terminated.
-
CLINICAL_TRIALS research · 2015-11-18Clinical Trial Update: Partnership in Medication Management (PIMM) in Patients With Mood Disorders [NA]
Clinical trial update on Partnership in Medication Management (PIMM) in patients with mood disorders; the status and phase are not provided.
-
CLINICAL_TRIALS trial_result · 2015-11-17Clinical Trial Update: Zinc, Mental Health, and School Performance in Guatemalan Schoolchildren [NA]
Update on a completed clinical trial evaluating zinc supplementation for depression and anxiety symptoms in Guatemalan schoolchildren.
-
CLINICAL_TRIALS trial_result · 2015-11-17Clinical Trial Update: Group Treatment for Adolescents With Depression [NA]
A clinical trial investigating group treatment for adolescents with depression has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-11-13Clinical Trial Update: Treatment of Post-Traumatic Brain Injury (TBI) Depression [Phase 2]
This update reports results from a Phase 2 trial evaluating treatment for depression following traumatic brain injury. The study conducted b…
-
CLINICAL_TRIALS trial_result · 2015-11-13Clinical Trial Update: NeuroStar TMS Therapy System: Utilization and Outcomes
This clinical trial update summarizes how the NeuroStar TMS Therapy System was utilized and the observed outcomes in patients with major dep…
-
FDA approval · 2015-11-12FDA Approved: ESCITALOPRAM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for escitalopram oxalate manufactured by Aurobindo Pharma Limited, updating the existing approval fo…
-
FDA approval · 2015-11-10FDA Approved: BUPROPION — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Bupropion submitted by Zydus Pharmaceuticals USA Inc. The approval indicates changes to the prod…